In cervical cancer, reduced levels of miR-34a has been reported as a result of p53 degradation by E6 [87]; therefore, metabolic reprogramming mediated by the absence of miR-34a could play an important role in cervical carcinogenesis (Figure 4). Here, TP53 is linked to cervical cancer.